The nomination committee in Integrum plans to propose the election of Anette Lindqvist as board member at an extraordinary general meeting

Integrum AB (publ), short name INTEG, the medical technology company that provides the bone-anchored OPRA™ Implant System to amputees, announces that the election committee of Integrum plans to propose the election of Anette Lindqvist as board member at an extra general meeting . Board member Patric Lindgren has informed the election committee that he has resigned from the board on December 18. Notice of the extraordinary general meeting will be issued shortly.

Presentation of Anette Lindqvist

Anette Lindqvist has a degree in business administration from Gothenburg School of Economics and executive independent courses from Harvard Business School in Boston and the Indian Institute of Management in Bangalore. With over 30 years of experience in the Life Science sector, she has held several leading positions in business development and senior positions in finance at companies such as AstraZeneca Plc., SOBI, Getinge and Mölnlycke Healthcare. She has also worked within GU Ventures and Chalmers. Anette is the founder and chairman of the board of Lynton Management AB. Currently, she is deputy managing director and chairman of the board for both Lynton Management AB and Bueneman Medic AB.

Anette Lindqvist is independent in relation to the Company and its management as well as to major shareholders.

Notice of the extraordinary general meeting will be issued shortly.

This disclosure contains information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 18-12-2024 15:07 CET.